quinazolines has been researched along with mln 8237 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonelli, A; Arlot-Bonnemains, Y; Baldini, E; Bononi, M; D'Armiento, M; Gnessi, L; Moretti, C; Morrone, S; Prinzi, N; Sorrenti, S; Tuccilli, C; Ulisse, S | 1 |
| Alessandrini, S; Baldini, E; Catania, A; Coccaro, C; D'Armiento, M; Filippini, A; Morrone, S; Prinzi, N; Rendina, R; Sorrenti, S; Tuccilli, C; Ulisse, S | 1 |
| Mehra, R; Zibelman, M | 1 |
| Gao, X; Liu, X; Niu, M; Pan, T; Qi, J; Wang, R; Wu, Q; Xu, K; Yao, Y; Zhang, H; Zhang, N; Zhong, X | 1 |
| Khan, T; Prabhu, A; Sankhe, K | 1 |
2 review(s) available for quinazolines and mln 8237
| Article | Year |
|---|---|
Overview of Current Treatment Options and Investigational Targeted Therapies for Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Topics: Afatinib; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azepines; Carcinoma, Squamous Cell; Cetuximab; Dasatinib; ErbB Receptors; Erlotinib Hydrochloride; Head and Neck Neoplasms; Humans; Lapatinib; Molecular Targeted Therapy; Panitumumab; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Quinazolinones; Signal Transduction; Sirolimus | 2016 |
Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancer.
Topics: Animals; Antineoplastic Agents; Aurora Kinase A; Azepines; Benzamides; Drug Approval; Drug Resistance; Drug Screening Assays, Antitumor; Flavones; Gene Expression Regulation; Humans; Indazoles; Neoplasms; Organophosphates; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Quinazolines; Structure-Activity Relationship | 2021 |
3 other study(ies) available for quinazolines and mln 8237
| Article | Year |
|---|---|
Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Aurora Kinase A; Aurora Kinase B; Azepines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Organophosphates; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Thyroid Carcinoma, Anaplastic | 2014 |
Preclinical testing of selective Aurora kinase inhibitors on a medullary thyroid carcinoma-derived cell line.
Topics: Aurora Kinase A; Aurora Kinase B; Azepines; Carcinoma, Neuroendocrine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Organophosphates; Pyrimidines; Quinazolines; Thyroid Neoplasms | 2016 |
Selective inhibition of Aurora A and B kinases effectively induces cell cycle arrest in t(8;21) acute myeloid leukemia.
Topics: Aurora Kinase A; Aurora Kinase B; Azepines; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Humans; Leukemia, Myeloid, Acute; Organophosphates; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Time Factors; Translocation, Genetic; Tumor Stem Cell Assay | 2019 |